MUPIROCIN OINTMENT

MUPIROCIN OINTMENT was reported 87 times

MUPIROCIN OINTMENT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACHLORHYDRIA 1 0.0143
1 PERITONITIS SCLEROSING 1 0.0120
2 APPLICATION SITE HYPOAESTHESIA 1 0.0043
3 TONGUE SPASM 1 0.0032
4 HEPATITIS ALCOHOLIC 1 0.0031
5 SENSATION OF BLOOD FLOW 1 0.0026
6 WOUND DRAINAGE 1 0.0013
7 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
8 TEMPORAL ARTERITIS 1 0.0011
9 WRONG SCHEDULE 1 0.0010
10 PRODUCT NAME CONFUSION 1 0.0009
11 NASAL PRURITUS 1 0.0008
12 APPLICATION SITE WARMTH 1 0.0008
13 NASAL DISCOMFORT 6 0.0008
14 IMPETIGO 1 0.0007
15 PATHOLOGICAL GAMBLING 1 0.0006
16 FEAR OF DISEASE 1 0.0006
17 NASAL OEDEMA 1 0.0006
18 INFECTED SKIN ULCER 1 0.0005
19 COMPULSIVE SHOPPING 1 0.0005
20 HEPATIC NEOPLASM MALIGNANT 1 0.0005
21 FEAR OF DEATH 1 0.0004
22 APPLICATION SITE SWELLING 2 0.0004
23 RADICULOPATHY 1 0.0004
24 INFUSION SITE REACTION 1 0.0003
25 REBOUND ACID HYPERSECRETION 1 0.0003
26 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
27 HEPATIC NEOPLASM 1 0.0003
28 TONGUE ULCERATION 1 0.0003
29 DIABETIC RETINOPATHY 1 0.0003
30 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
31 WOUND COMPLICATION 1 0.0003
32 DEPRESSION SUICIDAL 1 0.0003
33 APPLICATION SITE PAIN 6 0.0003
34 SCAB 3 0.0003
35 OESOPHAGEAL DISORDER 1 0.0003
36 TRIGGER FINGER 1 0.0002
37 BUNDLE BRANCH BLOCK LEFT 1 0.0002
38 POOR PERIPHERAL CIRCULATION 1 0.0002
39 PURULENT DISCHARGE 1 0.0002
40 CATHETERISATION CARDIAC 1 0.0002
41 DRUG EFFECT DELAYED 1 0.0002
42 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
43 SKIN TIGHTNESS 1 0.0002
44 RASH VESICULAR 1 0.0002
45 EXPIRED DRUG ADMINISTERED 1 0.0002
46 DRUG DISPENSING ERROR 3 0.0002
47 MALABSORPTION 1 0.0002
48 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
49 HERPES VIRUS INFECTION 1 0.0002
50 PRODUCT PRESCRIBING ERROR 4 0.0002
51 INFUSION SITE SWELLING 1 0.0002
52 APPLICATION SITE VESICLES 1 0.0002
53 APPLICATION SITE ERYTHEMA 4 0.0002
54 PRODUCT LABEL ISSUE 1 0.0001
55 DIVERTICULUM 1 0.0001
56 PRODUCT SUPPLY ISSUE 1 0.0001
57 RASH PUSTULAR 1 0.0001
58 RENAL FAILURE CHRONIC 1 0.0001
59 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
60 RENAL CYST 1 0.0001
61 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
62 ABNORMAL FAECES 1 0.0001
63 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
64 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
65 SENSATION OF FOREIGN BODY 1 0.0001
66 HYSTERECTOMY 1 0.0001
67 SPINAL OSTEOARTHRITIS 1 0.0001
68 ERYTHEMA MULTIFORME 1 0.0001
69 SLEEP APNOEA SYNDROME 2 0.0001
70 PRODUCT SUBSTITUTION ISSUE 6 0.0001
71 HYPERCHOLESTEROLAEMIA 1 0.0001
72 SINUS BRADYCARDIA 1 0.0001
73 LIGAMENT SPRAIN 1 0.0001
74 EMPHYSEMA 1 0.0001
75 JOINT DISLOCATION 1 0.0001
76 BIPOLAR DISORDER 1 0.0001
77 PRODUCT DISPENSING ERROR 2 0.0001
78 APPLICATION SITE PRURITUS 2 0.0001
79 RASH GENERALISED 2 0.0001
80 ORAL CANDIDIASIS 1 0.0001
81 ORAL DISCOMFORT 1 0.0001
82 CARPAL TUNNEL SYNDROME 1 0.0001
83 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
84 HYPOKINESIA 1 0.0001
85 SKIN HAEMORRHAGE 1 0.0001
86 HYPOAESTHESIA ORAL 1 0.0001
87 ECONOMIC PROBLEM 1 0.0001
88 SKIN DISCOLOURATION 3 0.0001
89 SWOLLEN TONGUE 2 0.0001
90 CYANOSIS 1 0.0001
91 SCIATICA 1 0.0001
92 MUSCLE TIGHTNESS 1 0.0001
93 IMPAIRED HEALING 2 0.0001
94 MANIA 1 0.0001
95 SCAR 1 0.0001
96 GALLBLADDER DISORDER 1 0.0001
97 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
98 END STAGE RENAL DISEASE 1 0.0001
99 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
100 MIDDLE INSOMNIA 1 0.0001
101 BLISTER 3 0.0001
102 HEPATIC CIRRHOSIS 1 0.0001
103 DRUG PRESCRIBING ERROR 1 0.0001
104 GLAUCOMA 1 0.0001
105 HERNIA 1 0.0001
106 ORAL HERPES 1 0.0001
107 FULL BLOOD COUNT DECREASED 1 0.0000
108 RIB FRACTURE 1 0.0000
109 MOUTH ULCERATION 1 0.0000
110 IMPAIRED WORK ABILITY 1 0.0000
111 IRRITABLE BOWEL SYNDROME 1 0.0000
112 SNEEZING 1 0.0000
113 BURNING SENSATION 3 0.0000
114 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
115 ERECTILE DYSFUNCTION 1 0.0000
116 SKIN ULCER 1 0.0000
117 MUSCULOSKELETAL PAIN 2 0.0000
118 PARAESTHESIA 6 0.0000
119 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
120 HAEMOPTYSIS 1 0.0000
121 TARDIVE DYSKINESIA 1 0.0000
122 ANGINA PECTORIS 1 0.0000
123 HYPERSOMNIA 1 0.0000
124 ACUTE MYOCARDIAL INFARCTION 1 0.0000
125 RENAL INJURY 1 0.0000
126 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
127 CORONARY ARTERY DISEASE 1 0.0000
128 STOMATITIS 2 0.0000
129 DRUG ADMINISTRATION ERROR 1 0.0000
130 CYSTITIS 1 0.0000
131 MOOD SWINGS 1 0.0000
132 CHOLELITHIASIS 1 0.0000
133 VIRAL INFECTION 1 0.0000
134 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
135 HYPERKALAEMIA 1 0.0000
136 LYMPHADENOPATHY 1 0.0000
137 SKIN BURNING SENSATION 2 0.0000
138 DRUG EFFECT INCOMPLETE 1 0.0000
139 DYSURIA 1 0.0000
140 DIABETES MELLITUS 2 0.0000
141 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
142 PSORIATIC ARTHROPATHY 1 0.0000
143 DYSKINESIA 1 0.0000
144 SKIN EXFOLIATION 2 0.0000
145 OSTEOARTHRITIS 1 0.0000
146 RENAL FAILURE ACUTE 1 0.0000
147 THROAT IRRITATION 1 0.0000
148 SKIN IRRITATION 1 0.0000
149 COGNITIVE DISORDER 1 0.0000
150 PRODUCT USE ISSUE 4 0.0000
151 RASH ERYTHEMATOUS 1 0.0000
152 DYSPEPSIA 2 0.0000
153 CELLULITIS 1 0.0000
154 SINUSITIS 2 0.0000
155 INFLAMMATION 1 0.0000
156 BRADYCARDIA 1 0.0000
157 DISTURBANCE IN ATTENTION 1 0.0000
158 THROMBOCYTOPENIA 2 0.0000
159 OXYGEN SATURATION DECREASED 1 0.0000
160 HYPONATRAEMIA 1 0.0000
161 HERPES ZOSTER 1 0.0000
162 DYSPHONIA 1 0.0000
163 NASAL CONGESTION 1 0.0000
164 ILL-DEFINED DISORDER 1 0.0000
165 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
166 PRURITUS 6 0.0000
167 AMNESIA 1 0.0000
168 PRODUCT QUALITY ISSUE 2 0.0000
169 HEPATIC ENZYME INCREASED 1 0.0000
170 INJURY 1 0.0000
171 EPISTAXIS 1 0.0000
172 HYPOAESTHESIA 2 0.0000
173 HALLUCINATION 1 0.0000
174 CHRONIC KIDNEY DISEASE 1 0.0000
175 INJECTION SITE SWELLING 1 0.0000
176 BACK PAIN 3 0.0000
177 CARDIAC FAILURE CONGESTIVE 1 0.0000
178 DRY MOUTH 1 0.0000
179 FALL 4 0.0000
180 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
181 PAIN 7 0.0000
182 OROPHARYNGEAL PAIN 1 0.0000
183 ANXIETY 3 0.0000
184 DYSPHAGIA 1 0.0000
185 NEUROPATHY PERIPHERAL 1 0.0000
186 ANAEMIA 2 0.0000
187 ATRIAL FIBRILLATION 1 0.0000
188 SYNCOPE 1 0.0000
189 SOMNOLENCE 2 0.0000
190 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
191 HYPERTENSION 2 0.0000
192 DEPRESSION 2 0.0000
193 PALPITATIONS 1 0.0000
194 DISEASE PROGRESSION 1 0.0000
195 FEELING ABNORMAL 2 0.0000
196 EMOTIONAL DISTRESS 1 0.0000
197 INJECTION SITE ERYTHEMA 1 0.0000
198 HYPERHIDROSIS 1 0.0000
199 RENAL FAILURE 1 0.0000
200 DEHYDRATION 1 0.0000
201 DRY SKIN 1 0.0000
202 VISION BLURRED 1 0.0000
203 COUGH 2 0.0000
204 DYSPNOEA 4 0.0000
205 INFECTION 1 0.0000
206 RASH 3 0.0000
207 OFF LABEL USE 6 0.0000
208 MALAISE 3 0.0000
209 HOSPITALISATION 1 0.0000
210 PERIPHERAL SWELLING 1 0.0000
211 DRUG INTERACTION 1 0.0000
212 DRUG DOSE OMISSION 1 0.0000
213 URTICARIA 1 0.0000
214 MUSCLE SPASMS 1 0.0000
215 NASOPHARYNGITIS 1 0.0000
216 CHEST PAIN 1 0.0000
217 DRUG INEFFECTIVE 7 0.0000
218 GAIT DISTURBANCE 1 0.0000
219 FATIGUE 4 0.0000
220 ERYTHEMA 1 0.0000
221 ARTHRALGIA 2 0.0000
222 CONSTIPATION 1 0.0000
223 ABDOMINAL PAIN 1 0.0000
224 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
225 DIZZINESS 2 0.0000
226 NAUSEA 3 0.0000
227 CONDITION AGGRAVATED 1 0.0000
228 PYREXIA 1 0.0000
229 HEADACHE 1 0.0000
230 DIARRHOEA 1 0.0000
231 DEATH 1 0.0000